Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Polymorphisms in the angiotensin I converting enzyme (ACE) gene are associated with multiple sclerosis risk and response to Interferon-β treatment.

Yaeghmaie R, Ghafouri-Fard S, Noroozi R, Tavakoli F, Taheri M, Ayatollahi SA.

Int Immunopharmacol. 2018 Sep 12;64:275-279. doi: 10.1016/j.intimp.2018.09.014. [Epub ahead of print]

PMID:
30218954
2.

Age-adjusted CSF β2-microglobulin and lactate are increased and ACE is decreased in patients with multiple sclerosis, but only lactate correlates with clinical disease duration and severity.

Haarmann A, Hähnel L, Schuhmann MK, Buttmann M.

J Neuroimmunol. 2018 Oct 15;323:19-27. doi: 10.1016/j.jneuroim.2018.07.001. Epub 2018 Jul 4.

PMID:
30196829
3.

SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage.

Faber I, Martinez ARM, de Rezende TJR, Martins CR Jr, Martins MP, Lourenço CM, Marques W Jr, Montecchiani C, Orlacchio A, Pedroso JL, Barsottini OGP, Lopes-Cendes Í, França MC Jr.

Neuroimage Clin. 2018 Jun 9;19:848-857. doi: 10.1016/j.nicl.2018.05.031. eCollection 2018.

4.

Cognitive behavioural therapy for MS-related fatigue explained: A longitudinal mediation analysis.

van den Akker LE, Beckerman H, Collette EH, Knoop H, Bleijenberg G, Twisk JW, Dekker J, de Groot V; TREFAMS-ACE study group.

J Psychosom Res. 2018 Mar;106:13-24. doi: 10.1016/j.jpsychores.2017.12.014. Epub 2017 Dec 28.

PMID:
29455894
5.

Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients.

Fahmy EM, Elfayoumy NM, Abdelalim AM, Sharaf SA, Ismail RS, Elshebawy H.

Int J Neurosci. 2018 Sep;128(9):835-841. doi: 10.1080/00207454.2018.1435538. Epub 2018 Feb 21.

PMID:
29384421
6.

Independent association of joint space narrowing, cyst formation and health-related quality of life of patients with hip osteoarthritis in Japan.

Takegami Y, Seki T, Higuchi Y, Komatsu D, Nishida Y, Ishiguro N.

J Orthop Sci. 2017 Nov;22(6):1096-1101. doi: 10.1016/j.jos.2017.08.014. Epub 2017 Sep 4.

PMID:
28882362
7.

The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.

Almeida-Santos AF, Kangussu LM, Campagnole-Santos MJ.

Protein Pept Lett. 2017 Nov 17;24(9):841-853. doi: 10.2174/0929866524666170822120258. Review.

PMID:
28828974
8.

Adverse Childhood Experiences Are Linked to Age of Onset and Reading Recognition in Multiple Sclerosis.

Shaw MT, Pawlak NO, Frontario A, Sherman K, Krupp LB, Charvet LE.

Front Neurol. 2017 Jun 2;8:242. doi: 10.3389/fneur.2017.00242. eCollection 2017.

9.

Meta Analysis of Human AlzGene Database: Benefits and Limitations of Using C. elegans for the Study of Alzheimer's Disease and Co-morbid Conditions.

Vahdati Nia B, Kang C, Tran MG, Lee D, Murakami S.

Front Genet. 2017 May 12;8:55. doi: 10.3389/fgene.2017.00055. eCollection 2017.

10.

Cognitive behavioral therapy positively affects fatigue in patients with multiple sclerosis: Results of a randomized controlled trial.

van den Akker LE, Beckerman H, Collette EH, Twisk JW, Bleijenberg G, Dekker J, Knoop H, de Groot V; TREFAMS-ACE Study Group.

Mult Scler. 2017 Oct;23(11):1542-1553. doi: 10.1177/1352458517709361. Epub 2017 May 22.

PMID:
28528567
11.

Does aerobic training alleviate fatigue and improve societal participation in patients with multiple sclerosis? A randomized controlled trial.

Heine M, Verschuren O, Hoogervorst EL, van Munster E, Hacking HG, Visser-Meily A, Twisk JW, Beckerman H, de Groot V, Kwakkel G; TREFAMS-ACE study group.

Mult Scler. 2017 Oct;23(11):1517-1526. doi: 10.1177/1352458517696596. Epub 2017 May 22.

12.

Effectiveness of energy conservation management on fatigue and participation in multiple sclerosis: A randomized controlled trial.

Blikman LJ, van Meeteren J, Twisk JW, de Laat FA, de Groot V, Beckerman H, Stam HJ, Bussmann JB; TREFAMS-ACE study group.

Mult Scler. 2017 Oct;23(11):1527-1541. doi: 10.1177/1352458517702751. Epub 2017 May 22.

PMID:
28528565
13.

Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report.

Ristić S, Starčević Čizmarević N, Lavtar P, Lovrečić L, Perković O, Sepčić J, Šega Jazbec S, Kapović M, Peterlin B.

Pharmacogenet Genomics. 2017 Jun;27(6):232-235. doi: 10.1097/FPC.0000000000000283.

PMID:
28430710
14.

The lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis.

Nadalin S, Buretić-Tomljanović A, Lavtar P, Starčević Čizmarević N, Hodžić A, Sepčić J, Kapović M, Peterlin B, Ristić S.

Brain Behav. 2016 Nov 14;7(1):e00600. doi: 10.1002/brb3.600. eCollection 2017 Jan.

15.

Real-Time Assessment of Fatigue in Patients With Multiple Sclerosis: How Does It Relate to Commonly Used Self-Report Fatigue Questionnaires?

Heine M, van den Akker LE, Blikman L, Hoekstra T, van Munster E, Verschuren O, Visser-Meily A, Kwakkel G; TREFAMS-ACE study group.

Arch Phys Med Rehabil. 2016 Nov;97(11):1887-1894.e1. doi: 10.1016/j.apmr.2016.04.019. Epub 2016 May 24.

PMID:
27233157
16.

Angiotensin-converting enzyme insertion/deletion gene polymorphism in multiple sclerosis: a meta-analysis.

Ristić S, Čizmarević NS, Sepčić J, Kapović M, Peterlin B.

Neurol Sci. 2016 Dec;37(12):1955-1959. Epub 2016 Aug 27.

PMID:
27568030
17.

The role of appraisal and coping style in relation with societal participation in fatigued patients with multiple sclerosis: a cross-sectional multiple mediator analysis.

van den Akker LE, Beckerman H, Collette EH, Bleijenberg G, Dekker J, Knoop H, de Groot V; TREFAMS-ACE study group.

J Behav Med. 2016 Oct;39(5):855-65. doi: 10.1007/s10865-016-9762-6. Epub 2016 Jul 2.

18.

Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.

Živković M, Kolaković A, Stojković L, Dinčić E, Kostić S, Alavantić D, Stanković A.

J Neurol Sci. 2016 Apr 15;363:29-32. doi: 10.1016/j.jns.2016.02.026. Epub 2016 Feb 12.

PMID:
27000216
19.
20.

Potential Use of Calpain Inhibitors as Brain Injury Therapy.

Cagmat EB, Guingab-Cagmat JD, Vakulenko AV, Hayes RL, Anagli J.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 40.

Supplemental Content

Loading ...
Support Center